Split History
ETFs Holding APVO »    APVO Historical Stock Prices »

Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aptevo Therapeutics is a clinical-stage, research and development biotechnology company focused on developing immunotherapeutic candidates for the treatment of different forms of cancer. Co.'s lead clinical candidates, APVO436 and ALG.APV-527, and preclinical candidates, APVO603 and APVO711, were developed using Co.'s ADAPTIR™ modular protein technology platform. Co.'s preclinical candidate APVO442 was developed using its ADAPTIR-FLEX™ modular protein technology platform. Co.'s ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of improving the human immune system against cancer cells. According to our APVO split history records, Aptevo Therapeutics has had 2 splits.
APVO split history picture
Aptevo Therapeutics (APVO) has 2 splits in our APVO split history database. The first split for APVO took place on March 27, 2020. This was a 1 for 14 reverse split, meaning for each 14 shares of APVO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 71.4285714285714 share position following the split. APVO's second split took place on March 06, 2024. This was a 1 for 44 reverse split, meaning for each 44 shares of APVO owned pre-split, the shareholder now owned 1 share. For example, a 71.4285714285714 share position pre-split, became a 1.62337662337662 share position following the split.

When a company such as Aptevo Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the APVO split history from start to finish, an original position size of 1000 shares would have turned into 1.62337662337662 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aptevo Therapeutics shares, starting with a $10,000 purchase of APVO, presented on a split-history-adjusted basis factoring in the complete APVO split history. APVO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/21/2016
End date: 04/12/2024
Start price/share: $4,928.00
End price/share: $0.84
Dividends collected/share: $0.00
Total return: -99.98%
Average Annual Total Return: -67.42%
Starting investment: $10,000.00
Ending investment: $1.72
Years: 7.73
Date Ratio
03/27/20201 for 14
03/06/20241 for 44
APVO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

AQB Split History
ARA Split History
ARGS Split History
ARNA Split History
ARTC Split History
ARWR Split History
ASMB Split History
ASNS Split History
ASTM Split History
ASTX Split History

Also explore: APVO shares outstanding history

Email EnvelopeFree APVO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

WiSA Technologies, Inc. (WISA)
Fluent, Inc. (FLNT)
TRACON Pharmaceuticals (TCON)
Agenus Inc. (AGEN)
Marin Software Incorporated (MRIN)
Nutex Health Inc. (NUTX)
Allarity Therapeutics, Inc. (ALLR)
Palisade Bio, Inc. (PALI)
Smith Micro Software, Inc. (SMSI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

APVO Insider Buying

APVO Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.